Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation (NICE - SUGAR STUDY)

PHASE4CompletedINTERVENTIONAL
Enrollment

6,104

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
HyperglycemiaCritical Illness
Interventions
OTHER

Intensive Insulin Therapy

Maintain blood glucose 4.5 - 6.o mmol/L

OTHER

Conventional Insulin therapy

Maintain blood glucose 8-10mmol/L

Trial Locations (1)

2050

The George Institute for International Health, Camperdown

All Listed Sponsors
collaborator

Australian and New Zealand Intensive Care Society Clinical Trials Group

NETWORK

collaborator

Canadian Critical Care Trials Group

OTHER

collaborator

National Health and Medical Research Council, Australia

OTHER

collaborator

Health Research Council, New Zealand

OTHER

collaborator

University of British Columbia

OTHER

lead

The George Institute

OTHER

NCT00220987 - Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation (NICE - SUGAR STUDY) | Biotech Hunter | Biotech Hunter